Q. Cai

发表

Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study.

Ming-wu Li, Y. Pang, Jingtao Gao, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Vitamin D receptor FokI gene polymorphism and tuberculosis susceptibility: a meta-analysis.

Q. Cai, Y. Sun, Sun Yp, 2015, Genetics and molecular research : GMR.

Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety

Ming-wu Li, Jichan Shi, Jingtao Gao, 2021, Infectious Diseases of Poverty.

Performance evaluation and clinical validation of optimized nucleotide MALDI-TOF-MS for mycobacterial identification

Libo Zhen, Shangzhi Cao, Lifang Sun, 2022, Frontiers in Cellular and Infection Microbiology.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

A. Spanevello, R. Duarte, D. Visca, 2019, European Respiratory Journal.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.

A. Spanevello, R. Duarte, E. Martínez Robles, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Diagnostic value of ultrasound‐guided transbronchial lung biopsy in peripheral tuberculous pulmonary lesions

Qi Qi, X. Zou, Q. Cai, 2022, Diagnostic cytopathology.

Identification of molecular subtypes and prognostic signatures based on transient receptor potential channel-related genes to predict the prognostic risk of hepatocellular carcinoma: A review

Dong Liu, Shudong Li, Jianxing Zheng, 2023, Medicine.

Continuity of TB services during the COVID-19 pandemic in China.

T. Cohen, J. Liu, J. Xia, 2021, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Continuity of services for patients with tuberculosis in China in the COVID-19 era

J. Xia, T. Cohen, Xiaolin Wang, 2020, medRxiv.

Hsa_circ_0001204 modulates inflammatory response of macrophages infected by Mycobacterium tuberculosis via TLR4/NF‐κB signalling pathway

Fang Wang, Libo Zhen, Q. Cai, 2022, Clinical and experimental pharmacology & physiology.

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort.

A. Spanevello, R. Duarte, E. Martínez Robles, 2021, Pulmonology.

Anlotinib-containing regimen for advanced small-cell lung cancer: A protocol of meta-analysis

Xudong Xu, Guocan Yu, Yanqin Shen, 2021, PloS one.

Identification of the key genes of tuberculosis and construction of a diagnostic model via weighted gene co-expression network analysis.

Libo Zhen, Lifang Sun, Meihua Qiu, 2023, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Mechanism underlying linezolid-induced peripheral neuropathy in multidrug-resistant tuberculosis

Suhang Guo, Yingying Xu, Jinmeng Li, 2022, Frontiers in Pharmacology.

New‐onset extrapulmonary tuberculosis in negative latent tuberculosis infection screening patients with Crohn's disease under anti‐TNF therapy in a tuberculosis‐endemic region: A case series

Yan Chen, Wen Hu, Shuyan Li, 2023, Journal of digestive diseases.

Prognostic significance of LRRC1 in hepatocellular carcinoma and construction of relevant prognostic model

Dong Liu, Xiaonan Chen, Jianxing Zheng, 2023, Medicine.

Safety, efficacy, and serum concentration monitoring of bedaquiline in Chinese patients with multidrug-resistant tuberculosis.

Jinmeng Li, Gaoyi Yang, Xin-jun Cai, 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.